Azopharma services support stand alone and full preclinical programs. Our GLP compliant operations are equipped to analyze biological samples for drug candidates and metabolites in biological matrices such as blood, plasma, urine, dialysate and tissues to support preclinical pharmacodynamics, pharmocokinetic, toxicology research and clinical programs.
Azopharma’s experienced scientists are capable of rapidly solving complex bioanalytical problems by developing and validating robust quantitative methods including cross-species and cross-matrix methods and applying those methods to high throughput sample analysis.
Azopharma’s breadth of technology, scientific expertise, rigorous GLP compliance programs and persistence to satisfy client needs give our clients high quality data and fast turn-around.
Service Overview:
- Methods development/validation
- Specimen analysis
- LC/MS/MS
- Derivatization techniques
- 96 well plate formats
- Metabolite ID and screening
- Peptide mapping
- Capillary electrophoresis
- Gel electrophoresis
- Statistical and data analysis
Capabilities:
- Sensitivity, linearity, separation and specificity used to qualify methods for pilot studies or preclinical animal studies
- Full validations done according to GLP and FDA Guidance
- Low-level analysis of drugs and metabolites in complex biological matrices
- High sample throughput
- Automated sample preparation
- Conventional HPLC (UV-Visible, fluorescence, and electrochemical detection)
- Analysis of unconventional biological tissues